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Background: Radical cystectomy (RC) is the standard treatment for patients with muscle-invasive bladder cancer
(BC), and it is also a valid option for selected patients with high-risk non-muscle-invasive BC. The purpose of this
study was to evaluate the effect on the lower skeletal muscle index (SMI) of short-term postoperative complications
of radical cystectomy (RC) in patients with bladder cancer (BC).
Methods: A total of 247 patients who received RC for BC and 204 age-matched healthy population-based controls
were retrospectively assessed. SMI was measured by preoperative computed tomography scans at the L4 to L5
level. Early complications were graded by Clavien-Dindo classification; severity of grade III or greater was identified
as a severe complication. Logistic regression was utilized to determine the relationships between covariables and
severe complications.
Results: A total of 125 (50.61%)/19 (7.69%) patients exhibited overall/severe complications during the early
postoperative period. SMI was strongly associated with gender (P <0.01), but not age and body mass index (BMI),
among patients with BC. Compared with the matched control group, BC patients exhibited lower SMI. The
difference was statistically significant in the subgroup of male patients (P = 0.03). In the multivariate analysis, SMI
was an independent predictor of developing severe complications. Each 1 cm2/m2 increase in SMI was associated
with a decrease in the odds of morbidity by 4.8%.
Conclusions: A lower SMI is frequently observed in bladder cancer patients undergoing RC and is shown to be
strongly associated with early complications following surgery.
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Radical cystectomy (RC) is the standard treatment for
patients with muscle-invasive bladder cancer (BC), and it is
also a valid option for selected patients with high-risk non-
muscle-invasive BC. RC includes simultaneous surgery on
the urinary tract, lymph nodes, and intestines; complica-
tions frequently occur after this extensive procedure. Using* Correspondence: dwyeli@163.com
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reproduction in any medium, provided the orstandardized reporting methods, early complication rates
ranged from 49% to 64% in a recently reported patient
series [1-3]. Therefore, identification of risk factors associ-
ated with complications following RC through individual
patient counseling, perioperative management planning
and evaluation of new treatments is warranted.
A recent study reported that morbidities following RC
are strongly associated with patient-related factors, such as
age, performance status, and comorbidities [3]. Although
these factors are important measurements of overall health
status, they do not enable accurate clinical decisions prior
to surgery. For example, reports concerning complications
of RC in older individuals often show contradictory and
completely opposite results. A substantial number ofd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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exhibit higher morbidities and could be safely performed
[4,5]. However, there are also studies that demonstrate a
significant increased risk of complications in old-old and
oldest-old patients [6,7]. A recent review of 20 studies of
older patients reported significant variation in complication
rates: ileus, from 2% to 32%; infection, from 5% to 39% [8].
Taken together, these diverse results suggest that chrono-
logical age alone does not sufficiently indicate the worst
outcome in older patients treated with RC. Therefore, an
improved predictor is needed to assess whether the patient
can tolerate such a complex surgical intervention.
Numerous studies have demonstrated that frailty is asso-
ciated with impaired mobility, disability, poor endurance,
and prolonged hospitalization [9-11]. Sarcopenia is a crit-
ical physiologic change underlying frailty that can occur as
a consequence of aging and malignant disease [12]. The
degree of sarcopenia can be quantified using the skeletal
muscle index (SMI) from the appearance of muscle on
cross-sectional images; this approach is attractive to sur-
geons because the images are objective and reproducible.
We hypothesized that if surgical complications following
RC are largely due to impaired resilience and recovery,
then a lower SMI could potentially serve as an important
prognostic indicator for high-risk surgical patients. In this
study, the relationship between lower SMI values and early
complications following RC was evaluated by standard
reporting methods in a patient cohort.
Methods
Patients and surgical intervention
This study was approved by the institutional review board
as a minimal-risk study and documented informed con-
sent was obtained from all patients. The medical records of
patients who underwent RC at Fudan University Shanghai
Cancer Center from July 2007 to March 2013 were retro-
spectively reviewed. Cases that fulfilled the following cri-
teria were collected: (1) pathological diagnosis of primary
BC; (2) preoperative cross-sectional pelvic computed tom-
ography (CT) images were available; (3) RC was performed
by experienced surgeons who had completed at least 50
procedures. A total of 247 patients were identified for fur-
ther analysis. Baseline characteristics, such as age, gender,
body mass index (BMI), performance status, Charlson
Comobidity Index (CCI), operation time, preoperative
hemoglobin, albumin and creatinine levels, and patho-
logical tumor stage and grade were collected.
To determine whether SMI is influenced by the burden
of tumor, we established an age-matched non-malignancy
control cohort in our study. A total of 204 age-matched
population-based controls with no evidence of malignancy
were selected from a positron emission topography-CT
(PET-CT) screen cohort. Indications for RC were muscle-
invasive BC or high-risk non-muscle-invasive BC refractoryto transurethral resection and intravesical therapy. Neoad-
juvant chemotherapy and/or radiotherapy were not utilized.
Indications for orthotopic ileal neobladder were absence of
disease at the level of the bladder neck and prostatic ur-
ethra, absence of urethral stricture, normal renal function,
and patient request for orthotropic bladder substitution.
Common contraindications included preoperative stress
urinary incontinence, significant comorbidities, and patient
unwillingness, unfitness, or inability (by surgeon judgment)
to comply with the voiding pattern required by the
neobladder.
Second-generation cephalosporin, metronidazole, and
elastic compressive stockings were used as prophylaxis
agents for infection and thromboembolic events in all
patients. Polyethylene glycol solution was routinely ad-
ministered the day before surgery for mechanical bowel
preparation. The majority of patients underwent the pro-
cedure under combined general and epidural anesthesia
with intrathecal postoperative analgesia.
A standard surgical procedure was performed in all pa-
tients, including meticulous pelvic lymphadenectomy with
en bloc RC as described by Skinner [13]. Orthotopic blad-
der substitution (according to the Studer ileal neobladder
technique [14]) or ileal conduit (according to the Bricker
technique [15]) were applied as bladder substitution. The
ureteroileal anastomosis was formed using the Nesbit
technique [15] with indwelling ureteric stents.
Postoperatively, a nasogastric tube remained in place for
all patients and was not removed until the first passage of
flatus. Intravenous antibiotics were used preoperatively.
The pelvic drainage tube was removed when drainage
fluid was less than 30 mL. Ureteric stents were removed
14 days after surgery. Patients with neobladder underwent
pouchogram on postoperative day 16 with the urethral
catheter removed when there was no significant leakage.
At our institution, patients were discharged home after
removal of drains, stents, and catheter.
Assessment of SMI
According to previous reports [16-20], total body skeletal
muscle volume can be evaluated by SMI. SMI = skeletal
muscle area (SMA)/height2. SMA was measured on one
cross-sectional scan obtained at the level of the umbilicus
(approximately the level of L4 and L5) with the patient in a
supine position. This imaging plane was utilized since it
strongly correlates with whole body skeletal muscle mass
[20] and is easily available in routine pelvic CT scans. As
shown in Figure 1, SMA can be calculated automatically
by ImageJ software (Version 1.44p, National Institutes of
Health, USA) on the basis of predefined Hounsfield unit
thresholds (116 to 165). Individuals (FW, YZ) were trained
to correctly identify and quantify lumbar vertebrae and the
following muscles: rectus abdominus, abdominal (lateral
and oblique), psoas, and paraspinal (quadratus lumborum,
Figure 1 Computed tomography image showing highlighted
areas of skeletal muscle mass (red). The protocol for measuring
areas of skeletal muscle mass is as follows: after converting image
type to 8-bit, set scale and double check the scale with the vertical
and horizontal ruler. Draw the two regions of interest (ROIs) including
the whole section and visceral only, respectively (in the inner line, we
excluded spinal cord because some part of spinal cord is at the same
density range). Use the XOR function to set the third ROI of the area
excluding visceral. Smooth the section twice to reduce noise of
image before setting the predefined threshold and measuring the
highlighted area.
Table 1 Demographic and clinicopathological
characteristics of the 247 patients included in our study
Characteristic Measure No. of patientsa
Sex ratio M:F 208:39
Age (years) Median (range) 61.0 (25 to 87)
BMI (kg/m2) Median (range) 22.8 (14.5 to 33.8)
Preoperative Hb (g/L) Median (range) 135.0 (53 to 167)
Preoperative Alb (g/L) Mean ± SD 40.9 ± 4.5
Preoperative Cr (μmol/L) Median (range) 76.0 (35 to 317)
ECOG 0 68 (27.6)
1 164 (66.4)
2 13 (5.3)
3 2 (0.8)
Age-adjusted CCI ≤4 76 (30.8)
>4, <7 123 (49.8)
≥7 48 (19,4)
Tumor grade II 23 (9.3)
III 224 (90.7)
T stageb Ta and Tis 21 (8.5)
T1 52 (21.0)
T2 83 (33.5)
T3 63 (25.4)
T4 27 (10.9)
N stageb N0 198 (79.8)
N1 17 (6.9)
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and the mean value was used for further analyses.
Definition and measurement of early complications
Early complications were recorded within 90 days of sur-
gery or during patient hospitalization. In accordance with
a recent review of various complications following RC
[21], we drafted a checklist for identification of complica-
tions from medical records. Complications were defined
by clinical and laboratory examinations with/without
radiological evaluation. The severity of complications was
graded according to Clavien-Dindo classification [22]. Any
complication of grade III or higher was defined as a severe
complication.N2 26 (10.5)
N3 6 (2.4)
M stage M0 242 (97.6)
M1 5 (2.0)
Urinary diversion Orthotopic neobladder 85 (34.3)
Ileal conduit 141 (57.1)
Ureterocutaneostomy 21 (8.5)
Operation time Median (range) 5.15 (2.08 to 8.58)
Hospital day Median (range) 20 (9 to 77)
aPercentages in parentheses unless indicated otherwise.
bT stage and N stage are pathological.
Alb albumin, BMI body mass index, CCI Charlson Comobidity Index, Cr creatine,
ECOG Eastern Cooperative Oncology Group, Hb hemoglobin.Statistical analyses
Continuous data were presented as median (range) and
category data were presented as proportions. A locally
weighted scatterplot smoothing curve and Pearson’s
correlation coefficient were used to address the rela-
tionship between paired continuous variables. The Stu-
dent’s t test was performed to test the difference in SMI
between categorical variables. Univariate and multivari-
ate logistic regression analyses were performed to evalu-
ate the associations between covariables and outcome.
All analyses were performed using R software (version
2.15.2, Institute for Statistics and Mathematics of theWU Wien, Vienna, Austria). The P value was two tailed
and considered significant when <0.05.
Results
A total of 208 (84.2%) male patients and 39 (15.8%) female
patients were enrolled in this study, mean age was 61.0
year. Detailed demographic and clinicopathological char-
acteristics of the 247 RC patients are shown in Table 1.
Table 2 shows the complete list of early postoperative
complications. In this cohort, a total of 177 complications
occurred in 125 (50.61%) patients. Among these 247
Table 2 Perioperative complication rates of 247 patients
who underwent radical cystectomy (RC)
Category
(n of totala)
Complication Frequencyb
Gastrointestinal Ileusc 37
Constipationd 12
Gastrointestinal bleeding 1
Bowel leak 2
Clostridium difficile colitis 2
Gastric ulcer 2
Infectious Fever of unknown origin 2
Urinary tract infection 33
Sepsis 5
Pyelonephritis 3
Gastroenteritis 1
Cholecystitis 1
Pelvic abscess 2
Wound Wound dehiscence 3
Surgical site infection 12
Genitourinary Renal failure 1
Hydronephrosis 5
Urinary leak 4
Necrosis of ileal conduit 1
Parastomal hernia 1
Testitis 1
Cardiac Arrhythmia 2
Myocardial infarction 3
Acute heart failure 3
Pulmonary Respiratory distress 1
Pneumonia 1
Bleeding Anemia requiring transfusion 2
Postoperative bleed other
than gastrointestinal
1
Thromboembolic Deep venous thrombosis 3
Pulmonary embolism 1
Neurological Peripheral neuropathy 1
Delirium/agitation 1
Surgical Vascular injury 1
Anastamotic bowel leak 2
Rectum injury 1
Miscellaneous Lymphatic leak 21
Other rare complications Ureter stent
broken 2
aReflects the percentage of patients with one or more complication within
the category.
bPatients experiencing multiple complications of different types are counted
more than once.
cIleus is defined as postoperative nausea or vomiting associated with abdominal
distension confirmed by radiological examination.
dConstipation is defined as inability to have a bowel movement by postoperative
day 5 with no signs of ileus or small bowel obstruction. Infectious complications
were diagnosed by positive culture. Prolonged lymphatic leak is defined as more
than 100 mL drainage output for 2 days starting from postoperative day 3.
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(21.86%) grade II, 7 (2.83%) grade III, 10 (4.05%) grade IV,
and 2 (0.81%) grade V. The rate of severe complication
(≥grade III) was 7.69%.
The measurement of SMI exhibited low interobserver
error (coefficient of variation 0.2% to 3.5%) and low
intraobserver error (coefficient of variation 0.9% to 2.9%).
A histogram of SMI showed normal distribution (data not
shown). Bivariate analysis revealed that SMI was signifi-
cantly associated with gender (P <0.01) but not strongly
correlated with age and BMI; in addition, SMI was not
associated with operation time (P = 0.789). The mean SMI
was 42.62 cm2/m2 in male patients, significantly higher
compared to female patients (31.79 cm2/m2, P <0.01). In
the age-matched control group, male subjects constituted
80.3% (164 of 204) and the mean age was 60.13 years. In
male subjects, SMI in the BC group was decreased signifi-
cantly compared with the control group (42.62 vs 45.10,
P = 0.031). However, in female subjects, SMI failed to
exhibit a statistically significant difference between the BC
group and control group (31.79 vs 32.48, P = 0.723).
We evaluated the associations between tested parameters
and overall/severe complications (Table 3). According to
univariate analysis, the likelihood of overall complications
increased dramatically as SMI decreased, if hypoalbumin-
emia was present and with higher tumor stage (American
Joint Committee on Cancer (AJCC) staging >2). In multi-
variate analysis, hypoalbuminemia and higher tumor stage
were independent predictors of morbidity. In univariate
analysis, the likelihood of severe complications increased
as SMI decreased and age increased (age >70). When other
risk factors were adjusted for, aging and lower SMI were
found to be independent predictors of severe complica-
tions. Each 1 cm2/m2 increase in SMI decreased the odds
of severe morbidity by 4.8%. After dividing patients into
four groups according to the value of SMI and BMI, the
highest probability of severe complications was observed in
cases with low SMI and high BMI (12.2%; nearly three
times higher than cases with high SMI and low BMI, 3.3%,
P = 0.076).
Discussion
Although surgical techniques have improved in recent
years, morbidity remains high for operational trauma. In
centers of excellence, morbidity ranges from 28% to 50%
[3,23,24]. Using standardized complication reporting meth-
odology, the prevalence of overall mortality was 50.61% in
our study, which is in concordance with previous reports.
Predictors of complications are needed to enable improved
decision making, assessment of eligibility for clinical trial,
and provide performance benchmarks. Muscle wasting is
recognized as a physical condition in the aged population
and is an emerging concern in patients with malignant
disease. A recent report indicates a positive link between
Table 3 Univariate and multivariate analysis for evaluation of the associations between tested parameters and short-term complications
Category Variables Overall Severe (grade ≥3)
Univariate Multivariate Univariate Multivariate
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Clinical Gendera 0.809 (0.408 to 1.606) 0.545 0.538 (0.120 to 2.407) 0.417
Agea 1.153 (0.698 to 1.904) 0.578 3.316 (1.068 to 10.298) 0.038 3.376 (1.074 to 10.614) 0.037
BMI 0.963 (0.887 to 1.044) 0.358 1.012 (0.876 to 1.170) 0.869
CCIa 1.528 (0.886 to 2.636) 0.128 0.891 (0.332 to 2.394) 0.802
ECOG 1.028 (0.468 to 2.257) 0.946 0.746 (0.205 to 2.714) 0.657
Nutritional Alba 2.780 (1.041 to 7.424) 0.041 3.628 (1.196 to 11.002) 0.023 1.942 (0.247 to 15.237) 0.528
Preoperative Hba 1.912 (0.622 to 5.876) 0.258 1.221 (0.152 to 9.819) 0.851
Cra 0.974 (0.406 to 2.337) 0.952 0.488 (0.062 to 3.822) 0.495
SMI 0.977 (0.955 to 1.000) 0.045 0.979 (0.954 to 1.004) 0.105 0.951 (0.916 to 0.987) 0.008 0.952 (0.915 to 0.991) 0.017
Tumor specific AJCCa 1.304 (1.004 to 1.693) 0.047 1.289 (0.986 to 1.685) 0.063 0.861 (0.334 to 2.220) 0.758
Grade 1.372 (0.577 to 3.258) 0.474 2.157 (0.276 to 16.854) 0.464
Surgical specific Diversiona 0.871 (0.518 to 1.466) 0.604 1.054 (0.409 to 2.272) 0.913
OT 0.980 (0.760 to 1.263) 0.876 0.826 (0.530 to 1.287) 0.397
aCategory variables: male patients versus female patients; diversion: orthotopic neobladder versus non-orthotopic neobladder; cut points are indicated as follows: age >70; preoperative Hb female patients <110 g/L or
male patients <120 g/L; Alb <35 g/L; creatine (Cr) >110; AJCC >2 or otherwise, CCI > 7.
AJCC American Joint Committee on Cancer, Alb albumin, BMI body mass index, CCI Charlson Comobidity Index, Cr creatine, ECOG Eastern Cooperative Oncology Group, Hb hemoglobin, OT operation time (h),
SMI skeletal muscle index.
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To the best of our knowledge, this study reports the
relationship between lower SMI and perioperative mor-
bidity of RC for the first time. In multivariate analysis,
SMI and aging are the two independent predicting fac-
tors of severe complications. We reviewed the medical
records and found that senior patients more frequently
experienced heart disease or deep vein thrombosis than
younger patients. These factors may explain why senior
age is correlated with severe complications but not
overall complications, and this is supported by several
previous reports [6,7]. SMI exhibited a negative rela-
tionship with short-term morbidity, whereas a positive
relationship was found between BMI and short-term
morbidity; high BMI tended to be associated with an
increased adverse event rate. In fact, Svatek previously
investigated this in RC patients and arrived at the same
conclusion (OR = 1.16, P <0.001) [3]. It is understood
that muscle wasting is not necessarily associated with
fat loss [26]. Covered by a mantle of adipose tissue,
muscle wasting is often an occult condition and
neglected by surgeons. In this study, we discovered that
patients with lower SMI as well as obesity were at the
highest risk of early complications. Therefore, these
findings suggest that SMI, which is quantified by the
appearance of muscle on cross-sectional imaging, could
be valuable in risk stratification and offer useful infor-
mation in clinical decision making, especially in patients
with BC under consideration for radical cystectomy.
Lower SMI is frequently observed in cancer patients
[27,28]. Compared to cachexia, lower SMI is more
prevalent in the early stages of disease. The reason for
exacerbation of lower SMI is multifactorial. First, some
risk factors of cancer are also strongly associated with
lower SMI. It has been independently reported that
aging and smoking are risk factors of both bladder
cancer and lower SMI [29-32]. Second, alteration of
metabolism is another hallmark of cancer. Cancer cells
are highly metabolic, leading to diminished homeostatic
reserves from release of endogenous transmitters and
changes in inflammatory markers and other mediators
[33,34]. Third, the treatment of cancer is commonly
accompanied by adverse events that may cause malnutri-
tion in patients. For example, reduced nutritional intake
(for example, anorexia) can be exacerbated by the side
effects of anticancer therapies [35].
Lower SMI is a modifiable prognostic factor of BC
patients undergoing RC. Malafarina et al. systemically
reviewed intervention of muscle wasting and concluded
that nutritional supplementation is an effective treat-
ment in older patients [36]. Nutritional supplementa-
tion could potentially lead to less morbidity and faster
recovery for BC patients undergoing RC, especially in
patients with lower SMI.Assessment of SMI is convenient in clinical practice
because only a single slice of CT is needed. As these
images are routinely available in clinical records, no extra
testing is usually required. Moreover, a surgeon can
measure the lumbar skeletal muscle within 5 minutes;
thus, it is an affordable and efficient method that is
specific, accurate, and sensitive to change.
Several limitations should be acknowledged in this pilot
study. Though the number of cases who experienced
severe complications was limited, validation is needed in a
larger population. Since this was a single center analysis,
further prospective studies in other centers are also
needed for validation. Our study included patients who
underwent radical cystectomy with available perioperative
CT scans; thus, there may be a selection bias regarding
patients excluded without available CT scans. Because the
ethnic population was limited to Asians, the distribution
of lumbar skeletal muscle index differs from the Western
population [37,38]. Therefore, the study should be vali-
dated in other ethnic populations as well.
Conclusions
SMI is a specific tool easily acquired in routine clinical
practice. Lower SMI is frequently observed in bladder
cancer patients undergoing RC and is shown to be
strongly associated with early complications following
surgery.
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